198 related articles for article (PubMed ID: 19898975)
1. Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.
Oita RC; Ferdinando D; Wilson S; Bunce C; Mazzatti DJ
Pflugers Arch; 2010 Mar; 459(4):619-30. PubMed ID: 19898975
[TBL] [Abstract][Full Text] [Related]
2. Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation.
Lin YT; Chen LK; Jian DY; Hsu TC; Huang WC; Kuan TT; Wu SY; Kwok CF; Ho LT; Juan CC
Cell Physiol Biochem; 2019; 52(6):1398-1411. PubMed ID: 31075190
[TBL] [Abstract][Full Text] [Related]
3. Visfatin, a novel adipokine, stimulates glucose uptake through the Ca2 +-dependent AMPK-p38 MAPK pathway in C2C12 skeletal muscle cells.
Lee JO; Kim N; Lee HJ; Lee YW; Kim JK; Kim HI; Lee SK; Kim SJ; Park SH; Kim HS
J Mol Endocrinol; 2015 Jun; 54(3):251-62. PubMed ID: 26019302
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts.
Kefaloyianni E; Gaitanaki C; Beis I
Cell Signal; 2006 Dec; 18(12):2238-51. PubMed ID: 16806820
[TBL] [Abstract][Full Text] [Related]
5. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
6. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
7. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity.
Romacho T; Azcutia V; Vázquez-Bella M; Matesanz N; Cercas E; Nevado J; Carraro R; Rodríguez-Mañas L; Sánchez-Ferrer CF; Peiró C
Diabetologia; 2009 Nov; 52(11):2455-2463. PubMed ID: 19727662
[TBL] [Abstract][Full Text] [Related]
8. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
[TBL] [Abstract][Full Text] [Related]
9. AMPK/FOXO1 signaling pathway is indispensable in visfatin-regulated myosin heavy chain expression in C2C12 myotubes.
Zhou LN; Lin YN; Gu CJ; Zhou JP; Sun XW; Cai XT; Du J; Li QY
Life Sci; 2019 May; 224():197-203. PubMed ID: 30926551
[TBL] [Abstract][Full Text] [Related]
10. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
11. Differential thiol oxidation of the signaling proteins Akt, PTEN or PP2A determines whether Akt phosphorylation is enhanced or inhibited by oxidative stress in C2C12 myotubes derived from skeletal muscle.
Tan PL; Shavlakadze T; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2015 May; 62():72-9. PubMed ID: 25737250
[TBL] [Abstract][Full Text] [Related]
12. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma Me45 cells.
Buldak RJ; Polaniak R; Buldak L; Mielanczyk L; Kukla M; Skonieczna M; Dulawa-Buldak A; Matysiak N; Zwirska-Korczala K
J Physiol Pharmacol; 2013 Jun; 64(3):377-85. PubMed ID: 23959735
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
Miethe C; Torres L; Zamora M; Price RS
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178
[TBL] [Abstract][Full Text] [Related]
14. Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway.
Cheng Q; Dong W; Qian L; Wu J; Peng Y
J Mol Endocrinol; 2011 Aug; 47(1):13-21. PubMed ID: 21471274
[TBL] [Abstract][Full Text] [Related]
15. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.
Fan Y; Meng S; Wang Y; Cao J; Wang C
Int J Mol Med; 2011 Apr; 27(4):607-15. PubMed ID: 21327328
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways.
Liu SL; Lin X; Shi DY; Cheng J; Wu CQ; Zhang YD
Arch Biochem Biophys; 2002 Oct; 406(2):173-82. PubMed ID: 12361705
[TBL] [Abstract][Full Text] [Related]
17. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
18. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
19. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species.
Kosmidou I; Vassilakopoulos T; Xagorari A; Zakynthinos S; Papapetropoulos A; Roussos C
Am J Respir Cell Mol Biol; 2002 May; 26(5):587-93. PubMed ID: 11970911
[TBL] [Abstract][Full Text] [Related]
20. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.
Wang P; Xu TY; Guan YF; Su DF; Fan GR; Miao CY
Cardiovasc Res; 2009 Feb; 81(2):370-80. PubMed ID: 18952695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
